首页 > 最新文献

Neurology Research International最新文献

英文 中文
Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis. 亚洲镰状细胞性贫血患者卒中患病率:系统回顾和荟萃分析
IF 1.5 Q3 Medicine Pub Date : 2021-06-03 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9961610
Sandip Kuikel, Robin Rauniyar, Sanjeev Kharel, Anil Bist, Subarna Giri, Sahil Thapaliya, Sunanda Paudel

Sickle cell anemia (SCA) is an inherited autosomal recessive disease. It is caused due to point mutation that substitutes glutamate with valine at the sixth amino acid position of the beta chain of hemoglobin molecules leading to the sickling of the red blood cells and decreased structural deformability. Silent cerebral infarcts are the most common neurological complication of SCA, while overt stroke comprises substantial burden in patients with SCA. This meta-analysis aimed to find the pooled prevalence of overt stroke in SCA patients and discuss the importance of screening them. PubMed, Embase, and Google Scholar were the electronic databases used to search the studies. A total of 765 articles were retrieved upon detailed searching in the abovementioned databases. After a series of removing duplicate articles, title and abstract screening, and full-text review, 20 articles were found eligible and included in the study. The total number of participants from all the included studies was 3,956, and pooled prevalence of stroke in patients with sickle cell anemia in Asia was found to be 5% (95% CI: 4%, 6%) with a range from 1 to 41%. Stroke occurrence in sickle cell anemia patients is an emergency complication that needs immediate intervention and management. Because of the high prevalence of stroke in patients with sickle cell anemia, clinicians should focus on its prevention and treatment strategies.

镰状细胞性贫血是一种遗传性常染色体隐性遗传病。这是由于血红蛋白分子β链第6个氨基酸位置的缬氨酸取代谷氨酸而引起的点突变,导致红细胞呈镰状,结构可变形性降低。无症状性脑梗死是SCA最常见的神经系统并发症,而显性脑卒中是SCA患者的主要负担。本荟萃分析旨在发现SCA患者公开性卒中的总患病率,并讨论筛查他们的重要性。PubMed, Embase和Google Scholar是用于搜索研究的电子数据库。在上述数据库中进行详细检索,共检索到765篇文章。经过一系列的删除重复文章,标题和摘要筛选,全文审查,20篇文章被纳入研究。所有纳入研究的参与者总数为3956人,亚洲镰状细胞性贫血患者卒中的总患病率为5% (95% CI: 4%, 6%),范围为1%至41%。镰状细胞性贫血患者发生脑卒中是一种紧急并发症,需要立即干预和管理。由于镰状细胞性贫血患者卒中发生率高,临床医生应关注其预防和治疗策略。
{"title":"Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis.","authors":"Sandip Kuikel,&nbsp;Robin Rauniyar,&nbsp;Sanjeev Kharel,&nbsp;Anil Bist,&nbsp;Subarna Giri,&nbsp;Sahil Thapaliya,&nbsp;Sunanda Paudel","doi":"10.1155/2021/9961610","DOIUrl":"https://doi.org/10.1155/2021/9961610","url":null,"abstract":"<p><p>Sickle cell anemia (SCA) is an inherited autosomal recessive disease. It is caused due to point mutation that substitutes glutamate with valine at the sixth amino acid position of the beta chain of hemoglobin molecules leading to the sickling of the red blood cells and decreased structural deformability. Silent cerebral infarcts are the most common neurological complication of SCA, while overt stroke comprises substantial burden in patients with SCA. This meta-analysis aimed to find the pooled prevalence of overt stroke in SCA patients and discuss the importance of screening them. PubMed, Embase, and Google Scholar were the electronic databases used to search the studies. A total of 765 articles were retrieved upon detailed searching in the abovementioned databases. After a series of removing duplicate articles, title and abstract screening, and full-text review, 20 articles were found eligible and included in the study. The total number of participants from all the included studies was 3,956, and pooled prevalence of stroke in patients with sickle cell anemia in Asia was found to be 5% (95% CI: 4%, 6%) with a range from 1 to 41%. Stroke occurrence in sickle cell anemia patients is an emergency complication that needs immediate intervention and management. Because of the high prevalence of stroke in patients with sickle cell anemia, clinicians should focus on its prevention and treatment strategies.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39250310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Clinical Evaluation and Treatment of Patients with Postconcussion Syndrome. 脑震荡后综合征的临床评价与治疗。
IF 1.5 Q3 Medicine Pub Date : 2021-05-29 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5567695
Vijay Renga

Postconcussion syndrome (PCS) is a complex set of symptoms occurring in a small percentage of patients following concussion. The condition is characterized by headaches, dizziness, cognitive difficulties, somatosensory issues, and a variety of other symptoms with varying durations. There is a lack of objective markers and standard treatment protocols. With the complexity created by premorbid conditions, psychosomatic issues, secondary gains, and litigations, providers often find themselves in a tough situation in the care of these patients. This article combines literature review and clinical insights with a focus on the underlying pathophysiology of PCS to provide a roadmap for evaluating and treating this condition.

脑震荡后综合征(PCS)是一组复杂的症状,发生在一小部分患者脑震荡后。这种疾病的特点是头痛、头晕、认知困难、躯体感觉问题和各种其他持续时间不同的症状。缺乏客观的标志和标准的治疗方案。由于病前状况、心身问题、继发收益和诉讼造成的复杂性,提供者经常发现自己在照顾这些患者时处于艰难的境地。本文结合文献综述和临床见解,重点关注PCS的潜在病理生理,为评估和治疗这种疾病提供路线图。
{"title":"Clinical Evaluation and Treatment of Patients with Postconcussion Syndrome.","authors":"Vijay Renga","doi":"10.1155/2021/5567695","DOIUrl":"https://doi.org/10.1155/2021/5567695","url":null,"abstract":"<p><p>Postconcussion syndrome (PCS) is a complex set of symptoms occurring in a small percentage of patients following concussion. The condition is characterized by headaches, dizziness, cognitive difficulties, somatosensory issues, and a variety of other symptoms with varying durations. There is a lack of objective markers and standard treatment protocols. With the complexity created by premorbid conditions, psychosomatic issues, secondary gains, and litigations, providers often find themselves in a tough situation in the care of these patients. This article combines literature review and clinical insights with a focus on the underlying pathophysiology of PCS to provide a roadmap for evaluating and treating this condition.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39045737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Screening of Cognitive Impairment in Patients with Multiple Sclerosis: A Cross-Sectional Study in Georgia. 多发性硬化症患者的认知障碍筛查:乔治亚州的一项横断面研究。
IF 1.5 Q3 Medicine Pub Date : 2021-05-27 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5591078
Nazibrola Botchorishvili, Nino Shiukashvili, Nina Mikeladze, Ann Dzagnidze, Nino Mikava, Maia Tighashvili, Marina Janelidze

Cognitive impairment (CI) is a common symptom of multiple sclerosis (MS), with a significant negative impact on the occupational and social functioning of patients. This study aimed to estimate the prevalence and characteristics of CI among MS patients in Georgia. Sixty-eight patients with MS attending a neurology outpatient clinic in Tbilisi, Georgia, were enrolled in the study. Cognitive status was evaluated using two screening tools: the Brief International Cognitive Assessment for MS and the Montreal Cognitive Assessment. The overall prevalence of CI in our MS patients was 47%. We found negative associations between cognitive test results and patients' age, disability status, and depression. Lower education, higher scores on the Expanded Disability Status Scale, and the progressive course of MS were the main predictors of CI in the logistic regression analysis. This is the first study in Georgia to evaluate CI in patients with MS. The prevalence of CI in our study was comparable with those reported in other countries; however, we found greater impairment of the executive system compared to other cognitive domains. In our study, patients who were on continuous DMT showed significantly better performance on the cognitive tests used, indicating possible favorable effect of immunomodulatory drugs on cognition.

认知障碍(CI)是多发性硬化症(MS)的常见症状,对患者的职业和社会功能有显著的负面影响。本研究旨在估计格鲁吉亚多发性硬化症患者CI的患病率和特征。在格鲁吉亚第比利斯一家神经病学门诊就诊的68名多发性硬化症患者参加了这项研究。认知状态评估使用两种筛查工具:MS的简要国际认知评估和蒙特利尔认知评估。MS患者CI的总体患病率为47%。我们发现认知测试结果与患者的年龄、残疾状况和抑郁症呈负相关。在logistic回归分析中,较低的教育程度、较高的扩展残疾状况量表得分和MS的进展过程是CI的主要预测因素。这是格鲁吉亚第一项评估ms患者CI的研究,我们研究中CI的患病率与其他国家的报道相当;然而,我们发现与其他认知领域相比,执行系统的损伤更大。在我们的研究中,持续服用DMT的患者在所使用的认知测试中表现出明显更好的表现,这表明免疫调节药物可能对认知有良好的作用。
{"title":"Screening of Cognitive Impairment in Patients with Multiple Sclerosis: A Cross-Sectional Study in Georgia.","authors":"Nazibrola Botchorishvili,&nbsp;Nino Shiukashvili,&nbsp;Nina Mikeladze,&nbsp;Ann Dzagnidze,&nbsp;Nino Mikava,&nbsp;Maia Tighashvili,&nbsp;Marina Janelidze","doi":"10.1155/2021/5591078","DOIUrl":"https://doi.org/10.1155/2021/5591078","url":null,"abstract":"<p><p>Cognitive impairment (CI) is a common symptom of multiple sclerosis (MS), with a significant negative impact on the occupational and social functioning of patients. This study aimed to estimate the prevalence and characteristics of CI among MS patients in Georgia. Sixty-eight patients with MS attending a neurology outpatient clinic in Tbilisi, Georgia, were enrolled in the study. Cognitive status was evaluated using two screening tools: the Brief International Cognitive Assessment for MS and the Montreal Cognitive Assessment. The overall prevalence of CI in our MS patients was 47%. We found negative associations between cognitive test results and patients' age, disability status, and depression. Lower education, higher scores on the Expanded Disability Status Scale, and the progressive course of MS were the main predictors of CI in the logistic regression analysis. This is the first study in Georgia to evaluate CI in patients with MS. The prevalence of CI in our study was comparable with those reported in other countries; however, we found greater impairment of the executive system compared to other cognitive domains. In our study, patients who were on continuous DMT showed significantly better performance on the cognitive tests used, indicating possible favorable effect of immunomodulatory drugs on cognition.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39239109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical and Paraclinical Screening for Celiac Disease in Children with Intractable Epilepsy. 顽固性癫痫患儿乳糜泻的临床及临床旁筛查。
IF 1.5 Q3 Medicine Pub Date : 2021-04-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/1639745
Golnaz Ghazizadeh Esslami, Bahar Allahverdi, Reza Shervin Badv, Morteza Heidari, Nahid Khosroshahi, Hosein Shabani-Mirzaee, Kambiz Eftekhari

Background: Celiac disease is the inflammatory entropy caused by hypersensitivity to gluten, which occurs in susceptible individuals. Some studies have suggested a link between celiac disease and epilepsy in children. Our aim was to screen for clinical and paraclinical features of celiac disease in children with intractable epilepsy.

Methods: This was a cross-sectional study. Children aged 2 to 18 years with refractory epilepsy that referred to the pediatric neurology clinic within one year (2018-2019) were enrolled. Demographic and clinical characteristics of patients, especially clinical manifestations of celiac disease, were recorded in a questionnaire. A venous blood sample was sent to determine the total IgA, anti-tTG (IgA), and anti-endomysial antibody (IgA). Endoscopy was performed in cases where the celiac serological test was positive.

Results: Seventy children with idiopathic drug-resistant epilepsy (44 boys) were evaluated. The height-for-age index was 49.2% and the weight-for-age index was 38.2% less than normal. Constipation (48.6%), anorexia (25.7%), and abdominal pain (21.4%) were the most common gastrointestinal symptoms. Celiac serological tests were negative in all children. Therefore, endoscopy and bowel biopsy were not performed in any case.

Conclusion: Celiac disease was not found in any patient with intractable epilepsy. Gastrointestinal symptoms and growth disorders in this group may be related to the underlying disease or medications and not to celiac disease.

背景:乳糜泻是由麸质过敏引起的炎症熵,发生在易感人群中。一些研究表明,乳糜泻和儿童癫痫之间存在联系。我们的目的是筛选难治性癫痫患儿乳糜泻的临床和临床旁特征。方法:采用横断面研究。研究纳入了一年内(2018-2019年)就诊于儿科神经病学诊所的2至18岁难治性癫痫患儿。调查问卷记录患者的人口学和临床特征,特别是乳糜泻的临床表现。静脉血检测总IgA、抗ttg (IgA)和抗肌内膜抗体(IgA)。在乳糜泻血清学检测阳性的病例中进行内窥镜检查。结果:对70例特发性耐药癫痫患儿(男孩44例)进行评价。身高年龄比正常值低49.2%,体重年龄比正常值低38.2%。便秘(48.6%)、厌食(25.7%)和腹痛(21.4%)是最常见的胃肠道症状。所有儿童的乳糜泻血清学试验均为阴性。因此,在任何情况下均未进行内窥镜检查和肠活检。结论:顽固性癫痫患者未发现乳糜泻。胃肠道症状和生长障碍可能与潜在疾病或药物有关,而与乳糜泻无关。
{"title":"Clinical and Paraclinical Screening for Celiac Disease in Children with Intractable Epilepsy.","authors":"Golnaz Ghazizadeh Esslami,&nbsp;Bahar Allahverdi,&nbsp;Reza Shervin Badv,&nbsp;Morteza Heidari,&nbsp;Nahid Khosroshahi,&nbsp;Hosein Shabani-Mirzaee,&nbsp;Kambiz Eftekhari","doi":"10.1155/2021/1639745","DOIUrl":"https://doi.org/10.1155/2021/1639745","url":null,"abstract":"<p><strong>Background: </strong>Celiac disease is the inflammatory entropy caused by hypersensitivity to gluten, which occurs in susceptible individuals. Some studies have suggested a link between celiac disease and epilepsy in children. Our aim was to screen for clinical and paraclinical features of celiac disease in children with intractable epilepsy.</p><p><strong>Methods: </strong>This was a cross-sectional study. Children aged 2 to 18 years with refractory epilepsy that referred to the pediatric neurology clinic within one year (2018-2019) were enrolled. Demographic and clinical characteristics of patients, especially clinical manifestations of celiac disease, were recorded in a questionnaire. A venous blood sample was sent to determine the total IgA, anti-tTG (IgA), and anti-endomysial antibody (IgA). Endoscopy was performed in cases where the celiac serological test was positive.</p><p><strong>Results: </strong>Seventy children with idiopathic drug-resistant epilepsy (44 boys) were evaluated. The height-for-age index was 49.2% and the weight-for-age index was 38.2% less than normal. Constipation (48.6%), anorexia (25.7%), and abdominal pain (21.4%) were the most common gastrointestinal symptoms. Celiac serological tests were negative in all children. Therefore, endoscopy and bowel biopsy were not performed in any case.</p><p><strong>Conclusion: </strong>Celiac disease was not found in any patient with intractable epilepsy. Gastrointestinal symptoms and growth disorders in this group may be related to the underlying disease or medications and not to celiac disease.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38964224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypnotic Effect of A. absinthium Hydroalcoholic Extract in Pentobarbital-Treated Mice. 苦艾水醇提取物对戊巴比妥治疗小鼠的催眠作用。
IF 1.5 Q3 Medicine Pub Date : 2021-04-21 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5521019
Hassan Rakhshandeh, Amirhossein Heidari, Ali Mohammad Pourbagher-Shahri, Roghayeh Rashidi, Fatemeh Forouzanfar

Background: Current drugs used in the management of insomnia are associated with side effects. The use of medicinal herbs for insomnia treatment has recently been suggested.

Objective: The present study aimed to determine the hypnotic activity of the hydroalcoholic extract of Artemisia absinthium (A. absinthium) in mice.

Method: The toxicity of A. absinthium extract is assessed by their lethal dose 50% (LD50), and cytotoxicity evaluation was also done with PC12 cell lines by MTT assay. A. absinthium extract (25, 50, 100, and 200 mg/kg) and 3 fractions (n-butanol fraction (NBF), ethyl acetate fraction (EAF), and aqueous fraction (AQF)) were administered intraperitoneally30 minutes before 30 mg/kg pentobarbital intraperitoneal injection; after that, the sleeping time and sleep latency were recorded.

Results: The LD50 value was 2.4 g/kg. The extracts tested showed no negative effect on the proliferation of PC12 cells. A. absinthium extract increased the duration of pentobarbital-induced sleep at doses of 100 and 200 mg/kg (P < 0.01-P < 0.001). Similarly, AQF, EAF, and NBF at 200 mg/kg could increase sleep duration (P < 0.05). The sleep latency was decreased by A. absinthium extract at doses of 100 and 200 mg/kg (P < 0.05-P < 0.01), AQF (P < 0.05), and EAF (P < 0.05). Besides, flumazenil reversed the hypnotic effect of A. absinthium extract (P < 0.05).

Conclusion: A. absinthium extract probably demonstrated sleep-enhancing effects by regulating GABAergic system.

背景:目前用于治疗失眠的药物存在副作用。最近有人建议用草药治疗失眠。目的:研究苦艾水醇提取物对小鼠的催眠作用。方法:以50%致死剂量(LD50)评价苦艾提取物的毒性,并采用MTT法对PC12细胞株进行细胞毒性评价。A.苦艾草提取物(25、50、100、200 mg/kg)和3个部分(正丁醇部分(NBF)、乙酸乙酯部分(EAF)、水溶液部分(AQF))在戊巴比妥30 mg/kg腹腔注射前30分钟腹腔注射;之后,记录睡眠时间和睡眠潜伏期。结果:LD50值为2.4 g/kg。所测提取物对PC12细胞的增殖无负面影响。苦艾草提取物在100和200 mg/kg剂量下增加戊巴比妥诱导的睡眠持续时间(P < 0.01-P < 0.001)。同样,200 mg/kg的AQF、EAF和NBF也能增加睡眠时间(P < 0.05)。苦艾草提取物100、200 mg/kg组(P < 0.05 ~ P < 0.01)、AQF (P < 0.05)和EAF (P < 0.05)均能显著降低大鼠睡眠潜伏期。苦艾草提取物(P < 0.05)。结论:苦艾草提取物可能通过调节gaba能系统发挥促睡眠作用。
{"title":"Hypnotic Effect of <i>A</i>. <i>absinthium</i> Hydroalcoholic Extract in Pentobarbital-Treated Mice.","authors":"Hassan Rakhshandeh, Amirhossein Heidari, Ali Mohammad Pourbagher-Shahri, Roghayeh Rashidi, Fatemeh Forouzanfar","doi":"10.1155/2021/5521019","DOIUrl":"10.1155/2021/5521019","url":null,"abstract":"<p><strong>Background: </strong>Current drugs used in the management of insomnia are associated with side effects. The use of medicinal herbs for insomnia treatment has recently been suggested.</p><p><strong>Objective: </strong>The present study aimed to determine the hypnotic activity of the hydroalcoholic extract of <i>Artemisia absinthium (A</i>. <i>absinthium)</i> in mice.</p><p><strong>Method: </strong>The toxicity of <i>A</i>. <i>absinthium</i> extract is assessed by their lethal dose 50% (LD50), and cytotoxicity evaluation was also done with PC12 cell lines by MTT assay. <i>A</i>. <i>absinthium</i> extract (25, 50, 100, and 200 mg/kg) and 3 fractions (<i>n</i>-butanol fraction (NBF), ethyl acetate fraction (EAF), and aqueous fraction (AQF)) were administered intraperitoneally30 minutes before 30 mg/kg pentobarbital intraperitoneal injection; after that, the sleeping time and sleep latency were recorded.</p><p><strong>Results: </strong>The LD50 value was 2.4 g/kg. The extracts tested showed no negative effect on the proliferation of PC12 cells. <i>A</i>. <i>absinthium</i> extract increased the duration of pentobarbital-induced sleep at doses of 100 and 200 mg/kg (<i>P</i> < 0.01-<i>P</i> < 0.001). Similarly, AQF, EAF, and NBF at 200 mg/kg could increase sleep duration (<i>P</i> < 0.05). The sleep latency was decreased by <i>A</i>. <i>absinthium</i> extract at doses of 100 and 200 mg/kg (<i>P</i> < 0.05-<i>P</i> < 0.01), AQF (<i>P</i> < 0.05), and EAF (<i>P</i> < 0.05). Besides, flumazenil reversed the hypnotic effect of <i>A</i>. <i>absinthium</i> extract (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong><i>A</i>. <i>absinthium</i> extract probably demonstrated sleep-enhancing effects by regulating GABAergic system.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38964225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Prediction Score for Cervical Spine Fracture in Patients with Traumatic Neck Injury. 外伤性颈损伤患者颈椎骨折预测评分。
IF 1.5 Q3 Medicine Pub Date : 2021-03-18 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6658679
Natsinee Athinartrattanapong, Chaiyaporn Yuksen, Sittichok Leela-Amornsin, Chetsadakon Jenpanitpong, Sirote Wongwaisayawan, Pittavat Leelapattana

Background: Cervical spine fracture is approximately 2%-5%. Diagnostic imaging in developing countries has several limitations. A computed tomography scan is not available 24 hours and not cost-effective. This study aims to develop a clinical tool to identify patients who must undergo a computed tomography scan to evaluate cervical spine fracture in a noncomputed tomography scan available hospital.

Methods: The study was a diagnostic prediction rule. A retrospective cross-sectional study was conducted between August 1, 2016, and December 31, 2018, at the emergency department. This study included all patients aged over 16 years who had suspected cervical spine injury and underwent a computed tomography scan at the emergency department. The predictive model and prediction scores were developed via multivariable logistic regression analysis.

Results: 375 patients met the criteria. 29 (7.73%) presented with cervical spine fracture on computed tomography scan and 346 did not. Five independent factors (i.e., high-risk mechanism of injury, paraparesis, paresthesia, limited range of motion of the neck, and associated chest or facial injury) were considered good predictors of C-spine fracture. The clinical prediction score for C-spine fracture was developed by dividing the patients into three probability groups (low, 0; moderate, 1-5; and high, 6-11), and the accuracy was 82.52%. In patients with a score of 1-5, the positive likelihood ratio for C-spine fracture was 1.46. Meanwhile, those with a score of 6-11 had an LR+ of 7.16.

Conclusion: In a noncomputed tomography scan available hospital, traumatic spine injuries patients with a clinical prediction score ≥1 were associated with cervical spine fracture and should undergo computed tomography scan to evaluate C-spine fracture.

背景:颈椎骨折发生率约为2%-5%。发展中国家的诊断成像存在一些局限性。计算机断层扫描不是24小时可用的,也不划算。本研究旨在开发一种临床工具,以确定在可用的非计算机断层扫描医院中必须接受计算机断层扫描以评估颈椎骨折的患者。方法:采用诊断预测法。回顾性横断面研究于2016年8月1日至2018年12月31日在急诊科进行。本研究包括所有年龄在16岁以上怀疑颈椎损伤并在急诊科接受计算机断层扫描的患者。通过多变量logistic回归分析建立预测模型和预测评分。结果:375例患者符合标准。29例(7.73%)在计算机断层扫描中表现为颈椎骨折,346例未见骨折。五个独立因素(即损伤的高危机制、麻痹、感觉异常、颈部活动范围受限以及相关的胸部或面部损伤)被认为是颈椎骨折的良好预测因素。颈椎骨折的临床预测评分通过将患者分为三个概率组(低,0;温和,1 - 5;6-11),准确率为82.52%。在1-5分的患者中,c -脊柱骨折的阳性似然比为1.46。与此同时,那些得分为6-11分的人的LR+为7.16。结论:在可进行非计算机断层扫描的医院,临床预测评分≥1分的外伤性脊柱损伤患者与颈椎骨折相关,应进行计算机断层扫描来评估颈椎骨折。
{"title":"Prediction Score for Cervical Spine Fracture in Patients with Traumatic Neck Injury.","authors":"Natsinee Athinartrattanapong,&nbsp;Chaiyaporn Yuksen,&nbsp;Sittichok Leela-Amornsin,&nbsp;Chetsadakon Jenpanitpong,&nbsp;Sirote Wongwaisayawan,&nbsp;Pittavat Leelapattana","doi":"10.1155/2021/6658679","DOIUrl":"https://doi.org/10.1155/2021/6658679","url":null,"abstract":"<p><strong>Background: </strong>Cervical spine fracture is approximately 2%-5%. Diagnostic imaging in developing countries has several limitations. A computed tomography scan is not available 24 hours and not cost-effective. This study aims to develop a clinical tool to identify patients who must undergo a computed tomography scan to evaluate cervical spine fracture in a noncomputed tomography scan available hospital.</p><p><strong>Methods: </strong>The study was a diagnostic prediction rule. A retrospective cross-sectional study was conducted between August 1, 2016, and December 31, 2018, at the emergency department. This study included all patients aged over 16 years who had suspected cervical spine injury and underwent a computed tomography scan at the emergency department. The predictive model and prediction scores were developed via multivariable logistic regression analysis.</p><p><strong>Results: </strong>375 patients met the criteria. 29 (7.73%) presented with cervical spine fracture on computed tomography scan and 346 did not. Five independent factors (i.e., high-risk mechanism of injury, paraparesis, paresthesia, limited range of motion of the neck, and associated chest or facial injury) were considered good predictors of C-spine fracture. The clinical prediction score for C-spine fracture was developed by dividing the patients into three probability groups (low, 0; moderate, 1-5; and high, 6-11), and the accuracy was 82.52%. In patients with a score of 1-5, the positive likelihood ratio for C-spine fracture was 1.46. Meanwhile, those with a score of 6-11 had an LR+ of 7.16.</p><p><strong>Conclusion: </strong>In a noncomputed tomography scan available hospital, traumatic spine injuries patients with a clinical prediction score ≥1 were associated with cervical spine fracture and should undergo computed tomography scan to evaluate C-spine fracture.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25558800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Novel Human-Centered Robotics: Towards an Automated Process for Neurorehabilitation. 新型以人为中心的机器人技术:迈向神经康复的自动化过程。
IF 1.5 Q3 Medicine Pub Date : 2021-01-29 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6690715
Meenakshi Devi Parre, B Sujatha

The global requirement of patient rehabilitation has surged with time due to the growing number of accidents, injuries, age-related issues, and other aspects. Parallelly, the cost of treatment and patient care also increased in a manifold. Moreover, constant monitoring and support for the patients having physical disabilities have become an ongoing challenge to the medical system. Robotics-based neurorehabilitation has reduced the human error while assisting such patients, precisely interpreting the signals, and communicating to the patient. Gradual precise application and improvement of the technology with time yielded a novel direction for patient care and support. The interdisciplinary contribution of many advanced technical branches allowed us to develop robotics-based assistance with high precision for the upper limb and the lower limb impairments. The present review summarizes the generation and background of robotic implementation for patient support, progress, present status, and future requirements.

由于事故、伤害、与年龄有关的问题和其他方面的日益增多,全球对患者康复的需求随着时间的推移而激增。与此同时,治疗和病人护理的费用也成倍增加。此外,对身体残疾患者的持续监测和支持已成为医疗系统面临的持续挑战。基于机器人的神经康复在帮助这些病人时减少了人为错误,精确地解释信号,并与病人沟通。随着时间的推移,该技术的逐步精确应用和改进为患者的护理和支持提供了新的方向。许多先进技术分支的跨学科贡献使我们能够为上肢和下肢损伤开发基于机器人的高精度辅助。本文综述了机器人在患者支持方面的产生和背景、进展、现状和未来需求。
{"title":"Novel Human-Centered Robotics: Towards an Automated Process for Neurorehabilitation.","authors":"Meenakshi Devi Parre,&nbsp;B Sujatha","doi":"10.1155/2021/6690715","DOIUrl":"https://doi.org/10.1155/2021/6690715","url":null,"abstract":"<p><p>The global requirement of patient rehabilitation has surged with time due to the growing number of accidents, injuries, age-related issues, and other aspects. Parallelly, the cost of treatment and patient care also increased in a manifold. Moreover, constant monitoring and support for the patients having physical disabilities have become an ongoing challenge to the medical system. Robotics-based neurorehabilitation has reduced the human error while assisting such patients, precisely interpreting the signals, and communicating to the patient. Gradual precise application and improvement of the technology with time yielded a novel direction for patient care and support. The interdisciplinary contribution of many advanced technical branches allowed us to develop robotics-based assistance with high precision for the upper limb and the lower limb impairments. The present review summarizes the generation and background of robotic implementation for patient support, progress, present status, and future requirements.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25351260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Psychometric Properties of Preference-Based Measures for Economic Evaluation in Amyotrophic Lateral Sclerosis: A Systematic Review. 肌萎缩性侧索硬化症经济评价中基于偏好的心理测量特性:系统综述。
IF 1.5 Q3 Medicine Pub Date : 2021-01-28 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6681554
Nicole Peters, Vanina Dal Bello-Haas, Tara Packham, Ava Mehdipour, Ayse Kuspinar

Objective: The aim of this review was to synthesize the psychometric properties of generic preference-based measures (PBMs) of health-related quality of life (HRQL) in Amyotrophic Lateral Sclerosis (ALS).

Methods: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases were searched from inception to April 2019: OVID Medline, Embase, PsycINFO, and CINAHL. Studies were included if (1) the sample represented individuals with ALS, (2) a generic PBM was utilized and reported on, and (3) information on the psychometric property of a generic PBM was provided.

Results: Ninety-one articles were screened, and 39 full-text articles were reviewed. Seven full-text articles were included in this review. The mean age of participants ranged from 58.1 to 63.8 years, and mean time since diagnosis ranged from 20.5 to 44.6 months. Two generic PBMs were found, the EQ-5D-3L (n = 6) and the Quality of Well-Being Self-Administered (QWB-SA) scale (n = 1). Convergent validity of the EQ-5D-3L was large against a global scale of self-perceived health (r = 0.60) and small to large against ALS specific HRQL measures (r = 0.19 to 0.75). For the QWB-SA scale, correlations were small against a generic measure (r = 0.21) and large against ALS specific measures (r = 0.55). The EQ-5D-3L discriminated across different disease severity; however, floor effects were reported.

Conclusion: This review highlights the need for more rigorously designed studies to assess the psychometric properties of generic PBMs in ALS and the development of an ALS specific PBM that adequately reflects the health concerns of individuals with ALS.

目的:本综述的目的是综合肌萎缩性侧索硬化症(ALS)患者健康相关生活质量(HRQL)的通用偏好测量(PBMs)的心理测量特性。方法:根据系统评价和荟萃分析指南的首选报告项目进行系统评价。从成立到2019年4月检索了四个数据库:OVID Medline、Embase、PsycINFO和CINAHL。如果(1)样本代表ALS患者,(2)使用并报告了通用PBM,以及(3)提供了通用PBM的心理测量特性信息,则纳入研究。结果:共筛选文章91篇,回顾全文39篇。本综述纳入了七篇全文文章。参与者的平均年龄为58.1至63.8岁,平均诊断时间为20.5至44.6个月。我们发现了两个通用的PBMs, EQ-5D-3L (n = 6)和幸福自我管理质量(QWB-SA)量表(n = 1)。EQ-5D-3L的收敛效度在自我感知健康的整体量表上较大(r = 0.60),在ALS特异性HRQL量表上由小到大(r = 0.19至0.75)。对于QWB-SA量表,与一般测量值的相关性较小(r = 0.21),与ALS特异性测量值的相关性较大(r = 0.55)。EQ-5D-3L在不同疾病严重程度中具有区别;然而,报告了地板效应。结论:本综述强调需要更严格设计的研究来评估ALS的通用PBM的心理测量特性,并开发ALS特异性PBM,以充分反映ALS患者的健康问题。
{"title":"Psychometric Properties of Preference-Based Measures for Economic Evaluation in Amyotrophic Lateral Sclerosis: A Systematic Review.","authors":"Nicole Peters,&nbsp;Vanina Dal Bello-Haas,&nbsp;Tara Packham,&nbsp;Ava Mehdipour,&nbsp;Ayse Kuspinar","doi":"10.1155/2021/6681554","DOIUrl":"https://doi.org/10.1155/2021/6681554","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this review was to synthesize the psychometric properties of generic preference-based measures (PBMs) of health-related quality of life (HRQL) in Amyotrophic Lateral Sclerosis (ALS).</p><p><strong>Methods: </strong>A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases were searched from inception to April 2019: OVID Medline, Embase, PsycINFO, and CINAHL. Studies were included if (1) the sample represented individuals with ALS, (2) a generic PBM was utilized and reported on, and (3) information on the psychometric property of a generic PBM was provided.</p><p><strong>Results: </strong>Ninety-one articles were screened, and 39 full-text articles were reviewed. Seven full-text articles were included in this review. The mean age of participants ranged from 58.1 to 63.8 years, and mean time since diagnosis ranged from 20.5 to 44.6 months. Two generic PBMs were found, the EQ-5D-3L (<i>n</i> = 6) and the Quality of Well-Being Self-Administered (QWB-SA) scale (<i>n</i> = 1). Convergent validity of the EQ-5D-3L was large against a global scale of self-perceived health (<i>r</i> = 0.60) and small to large against ALS specific HRQL measures (<i>r</i> = 0.19 to 0.75). For the QWB-SA scale, correlations were small against a generic measure (<i>r</i> = 0.21) and large against ALS specific measures (<i>r</i> = 0.55). The EQ-5D-3L discriminated across different disease severity; however, floor effects were reported.</p><p><strong>Conclusion: </strong>This review highlights the need for more rigorously designed studies to assess the psychometric properties of generic PBMs in ALS and the development of an ALS specific PBM that adequately reflects the health concerns of individuals with ALS.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25360325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensitivity of Awaji Criteria and Revised El Escorial Criteria in the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) at First Visit in a Tunisian Cohort. Awaji标准和修订El Escorial标准在突尼斯队列中首次就诊时诊断肌萎缩性侧索硬化症(ALS)的敏感性
IF 1.5 Q3 Medicine Pub Date : 2021-01-22 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8841281
Bademain Jean Fabrice Ido, Imen Kacem, Mahamadi Ouedraogo, Amina Nasri, Saloua Mrabet, Amina Gargouri, Mouna Ben Djebara, Bawindsongré Jean Kabore, Riadh Gouider

Background: Amyotrophic lateral sclerosis (ALS) is a fatal disease whose diagnosis and early management can improve survival. The most used diagnostic criteria are the revised El Escorial criteria (rEEC) and Awaji criteria (AC). The comparison of their sensitivities showed contradictory results. Our study aimed to compare the sensitivities of these two criteria in the diagnosis of definite ALS, at first visit, in a Tunisian hospital cohort.

Materials and methods: This was a retrospective study including 173 patients diagnosed with ALS at the Department of Neurology of the Razi Hospital between January 2003 and April 2018.After studying the clinical features of the disease in our study population,each patient was categorized according to the rEEC and AC based on data collected in his medical record during his first visit to our department. Then, we compared the sensitivities of these two criteria in the diagnosis of definite ALS.

Results: Our Tunisian cohort was characterized by a slower disease progression. The sensitivity of the AC (69.4%) was significantly higher than that of the rEEC (40.5%) (p < 0.001). When the clinical signs evolved for less than 6 months, the sensitivities were 61% for AC and 12% for rEEC (p < 0.001). After 24 months of disease progression, the sensitivities were 78.2% for AC and 69.1% for rEEC (p = 0.063). It was impossible to categorize seventeen patients by the two criteria.

Conclusion: Our study demonstrated that patients in AC are more sensitive than rEEC in the early diagnosis of ALS in our Tunisian cohort. However, this superiority is gradually reduced during the evolution of the disease.

背景:肌萎缩性侧索硬化症(ALS)是一种致命的疾病,其诊断和早期治疗可以提高生存率。最常用的诊断标准是经修订的El Escorial标准(rEEC)和Awaji标准(AC)。它们的灵敏度比较显示出相互矛盾的结果。我们的研究旨在比较这两个标准在诊断明确ALS的敏感性,在突尼斯医院队列首次访问。材料和方法:这是一项回顾性研究,包括2003年1月至2018年4月期间在Razi医院神经内科诊断为ALS的173例患者。在研究了我们研究人群中疾病的临床特征后,根据患者首次来我科就诊时的病历资料,将每位患者按照rEEC和AC进行分类。然后,我们比较了这两个标准在诊断明确ALS中的敏感性。结果:我们的突尼斯队列的特点是疾病进展较慢。AC的灵敏度(69.4%)显著高于rEEC (40.5%) (p p p = 0.063)。根据这两个标准对17例患者进行分类是不可能的。结论:我们的研究表明,在我们的突尼斯队列中,AC患者比rEEC患者对ALS的早期诊断更敏感。然而,这种优势在疾病的发展过程中逐渐减少。
{"title":"Sensitivity of Awaji Criteria and Revised El Escorial Criteria in the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) at First Visit in a Tunisian Cohort.","authors":"Bademain Jean Fabrice Ido,&nbsp;Imen Kacem,&nbsp;Mahamadi Ouedraogo,&nbsp;Amina Nasri,&nbsp;Saloua Mrabet,&nbsp;Amina Gargouri,&nbsp;Mouna Ben Djebara,&nbsp;Bawindsongré Jean Kabore,&nbsp;Riadh Gouider","doi":"10.1155/2021/8841281","DOIUrl":"https://doi.org/10.1155/2021/8841281","url":null,"abstract":"<p><strong>Background: </strong>Amyotrophic lateral sclerosis (ALS) is a fatal disease whose diagnosis and early management can improve survival. The most used diagnostic criteria are the revised El Escorial criteria (rEEC) and Awaji criteria (AC). The comparison of their sensitivities showed contradictory results. Our study aimed to compare the sensitivities of these two criteria in the diagnosis of definite ALS, at first visit, in a Tunisian hospital cohort.</p><p><strong>Materials and methods: </strong>This was a retrospective study including 173 patients diagnosed with ALS at the Department of Neurology of the Razi Hospital between January 2003 and April 2018.After studying the clinical features of the disease in our study population,each patient was categorized according to the rEEC and AC based on data collected in his medical record during his first visit to our department. Then, we compared the sensitivities of these two criteria in the diagnosis of definite ALS.</p><p><strong>Results: </strong>Our Tunisian cohort was characterized by a slower disease progression. The sensitivity of the AC (69.4%) was significantly higher than that of the rEEC (40.5%) (<i>p</i> < 0.001). When the clinical signs evolved for less than 6 months, the sensitivities were 61% for AC and 12% for rEEC (<i>p</i> < 0.001). After 24 months of disease progression, the sensitivities were 78.2% for AC and 69.1% for rEEC (<i>p</i> = 0.063). It was impossible to categorize seventeen patients by the two criteria.</p><p><strong>Conclusion: </strong>Our study demonstrated that patients in AC are more sensitive than rEEC in the early diagnosis of ALS in our Tunisian cohort. However, this superiority is gradually reduced during the evolution of the disease.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25341755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Parkinson's Disease Gravity Index: A Method by means of Optimal Scaling. 帕金森病重力指数:通过优化比例的方法。
IF 1.7 Q4 NEUROSCIENCES Pub Date : 2020-12-15 eCollection Date: 2020-01-01 DOI: 10.1155/2020/8871870
Marcos Serrano-Dueñas, Luis Masabanda, Maria-Rosario Luquin

Objective: This study has been designed with the aim of using optimal scaling to perform the allocation of scores and to be able to construct an indicator of the Parkinson's Disease Gravity Index. Scores were assigned to interrelated dimensions that share information about the patient's situation, to have an objective, holistic tool which integrates scores so that doctors can have a comprehensive idea of the patient's situation. Patients and Methods. 120 consecutive patients with Parkinson's diagnosis were chosen according to the United Kingdom Parkinson's Disease Society Brain Bank criteria. Subsequently, all the chosen dimensions were transformed into interval variables for which the formula proposed by Sturges was used. Once the dimensions were transformed into interval variables, optimal scaling was carried out. Subsequently, the following attributes were analyzed: quality and acceptability of the data; reliability: internal consistency, reliability index, Cronbach's alpha, and standard error of measurement; finally, validity: convergent validity and validity for known groups.

Results: There were no missing data. An appropriate Cronbach's alpha value of 0.71 was gathered, and all items were found to be pertinent to the scale. The item homogeneity index was 0.36. Precision evaluated with the standard error of measurement was 7.8. The Parkinson's Disease Gravity Index discriminant validity (validity for known groups), assessed among the different stages of Hoehn and Yahr scale by the Kruskal-Wallis test, showed major significance (X 2 = 32.7, p ≤ 0.001).

Conclusions: The Parkinson's Disease Gravity Index has shown adequate metric properties.

研究目的本研究旨在使用最佳比例来分配分数,并构建帕金森病重力指数指标。将分数分配给相互关联的维度,这些维度共享有关患者情况的信息,从而形成一个客观、全面的工具,将分数整合在一起,使医生能够全面了解患者的情况。患者和方法根据英国帕金森病协会脑库标准,连续挑选了 120 名帕金森病患者。随后,将所有选定的维度转化为区间变量,并使用 Sturges 提出的公式进行计算。将维度转换为区间变量后,进行了优化缩放。随后,对以下属性进行了分析:数据的质量和可接受性;可靠性:内部一致性、可靠性指数、克朗巴赫α和测量标准误差;最后是有效性:收敛有效性和已知群体的有效性:结果:没有数据缺失。Cronbach's alpha 值为 0.71,所有项目均与量表相关。项目同质性指数为 0.36。用测量标准误差评估的精确度为 7.8。通过 Kruskal-Wallis 检验对 Hoehn 和 Yahr 量表不同阶段的帕金森病重力指数判别效度(已知组别效度)进行了评估,结果显示其具有显著性(X 2 = 32.7,P ≤ 0.001):帕金森病重力指数显示了适当的度量特性。
{"title":"Parkinson's Disease Gravity Index: A Method by means of Optimal Scaling.","authors":"Marcos Serrano-Dueñas, Luis Masabanda, Maria-Rosario Luquin","doi":"10.1155/2020/8871870","DOIUrl":"10.1155/2020/8871870","url":null,"abstract":"<p><strong>Objective: </strong>This study has been designed with the aim of using optimal scaling to perform the allocation of scores and to be able to construct an indicator of the Parkinson's Disease Gravity Index. Scores were assigned to interrelated dimensions that share information about the patient's situation, to have an objective, holistic tool which integrates scores so that doctors can have a comprehensive idea of the patient's situation. <i>Patients and Methods.</i> 120 consecutive patients with Parkinson's diagnosis were chosen according to the United Kingdom Parkinson's Disease Society Brain Bank criteria. Subsequently, all the chosen dimensions were transformed into interval variables for which the formula proposed by Sturges was used. Once the dimensions were transformed into interval variables, optimal scaling was carried out. Subsequently, the following attributes were analyzed: quality and acceptability of the data; reliability: internal consistency, reliability index, Cronbach's alpha, and standard error of measurement; finally, validity: convergent validity and validity for known groups.</p><p><strong>Results: </strong>There were no missing data. An appropriate Cronbach's alpha value of 0.71 was gathered, and all items were found to be pertinent to the scale. The item homogeneity index was 0.36. Precision evaluated with the standard error of measurement was 7.8. The Parkinson's Disease Gravity Index discriminant validity (validity for known groups), assessed among the different stages of Hoehn and Yahr scale by the Kruskal-Wallis test, showed major significance (<i>X</i> <sup>2</sup> = 32.7, <i>p</i> ≤ 0.001).</p><p><strong>Conclusions: </strong>The Parkinson's Disease Gravity Index has shown adequate metric properties.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2020-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38767732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurology Research International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1